A recent story from “MarketWatch”, a financial website and subsidiary of the Dow Jones’ Consumer Media Group, has revealed a new development in the advisory board of ImmunoClin: molecular biologist and virologist Dr. Marco Kaiser has been named to the influential company’s advisory board. Dr. Kaiser is an accomplished scholar who is currently an integral member of GenExpress GmbH, a German molecular biology company. Before his involvement with GenExpress, Dr. Kaiser attended the Technical University of Berlin, where he studied medical biotechnology. His devoted studies led him to Berlin’s Centre for Biological Threats and Specific Pathogens at the renowned Robert Koch Institute, where he completed his doctoral thesis on “Ultra sensitive multiplex diagnostics for emerging pathogens”. He also has a lot of experience in development of technologies geared to dermatological and virology research, is credited with authoring several scientific papers, and has given numerous oral presentations. Dr. Kaiser has expressed enthusiasm with his new position at ImmunoClin, citing his background in molecular biology and experience in tech development for tools that can be used for pathogen detection.
On the other hand, ImmunoClin looks forward to welcoming Dr. Marco Kaiser with warmly wide open arms. They believe they can derive a great deal of knowledge and insight from Kaiser, which in turn can be used to further the company’s innovation and creativity. But what does Immunoclin actually do?
ImmunoClin is an American-based healthcare company, that specializes in the development of personalized medicine. The company prides itself on it’s innovative tactics, novel therapy, personalized medicine, and creative and insightful nutritional therapy. The molecular biology-heavy background of Kaiser is expected to be of great use to the company. Though it is an American company, ImmunoClin has several offices abroad, including ones in Paris and London. The innovation that ImmunoClin focuses on surround the development of personalized and unique therapies to combat anti-inflammatory conditions that happen to be player in several conditions affecting the human population, such as dementia, cancer, and cardiovascular disease.